Berlin - Delayed Quote EUR

Satellos Bioscience Inc (0ITA.BE)

Compare
0.6700 +0.0300 (+4.69%)
As of 3:54:04 PM GMT+1. Market Open.
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cost of Revenue
206.9370
--
--
119.9190
48.1610
Gross Profit
-206.9370
--
--
-119.9190
-48.1610
Operating Expense
26,243.0000
15,463.0000
8,428.0000
4,701.3520
1,427.0510
Operating Income
-26,243.0000
-15,463.0000
-8,428.0000
-4,701.3520
-1,475.2120
Net Non Operating Interest Income Expense
1,648.0000
1,156.0000
63.0000
-977.3460
-18.0780
Other Income Expense
-3,933.0000
-1,582.0000
-2,952.0000
-9,826.9540
-85.2400
Pretax Income
-28,528.0000
-15,889.0000
-11,317.0000
-15,505.6520
-1,578.5300
Tax Provision
--
--
5.0000
--
--
Net Income Common Stockholders
-28,528.0000
-15,889.0000
-11,322.0000
-15,505.6520
-1,578.5300
Diluted NI Available to Com Stockholders
-28,528.0000
-15,889.0000
-11,322.0000
-15,505.6520
-1,578.5300
Basic EPS
-0.25
-0.18
-0.32
-0.64
-0.05
Diluted EPS
-0.25
-0.18
-0.32
-0.64
-0.05
Basic Average Shares
112,852.0830
86,404.7620
35,680.1130
24,076.4570
32,866.7480
Diluted Average Shares
112,852.0830
86,404.7620
35,680.1130
24,076.4570
32,866.7480
Total Operating Income as Reported
-26,243.0000
-15,463.0000
-8,428.0000
--
--
Total Expenses
26,243.0000
15,463.0000
8,428.0000
4,701.3520
1,475.2120
Net Income from Continuing & Discontinued Operation
-28,528.0000
-15,889.0000
-11,322.0000
-15,505.6520
-1,578.5300
Normalized Income
-24,595.0000
-14,307.0000
-9,143.7192
-5,722.5390
-1,568.2970
Interest Income
1,648.0000
1,333.0000
63.0000
7.9860
4.9710
Interest Expense
--
177.0000
--
985.3320
23.0490
Net Interest Income
1,648.0000
1,156.0000
63.0000
-977.3460
-18.0780
EBIT
-28,528.0000
-15,712.0000
-11,317.0000
-14,520.3200
-1,555.4810
EBITDA
-28,518.0000
-15,705.0000
-10,980.0000
-14,354.6350
-1,555.0590
Reconciled Cost of Revenue
206.9370
--
--
119.9190
48.1610
Reconciled Depreciation
10.0000
7.0000
337.0000
165.6850
0.4220
Net Income from Continuing Operation Net Minority Interest
-28,528.0000
-15,889.0000
-11,322.0000
-15,505.6520
-1,578.5300
Total Unusual Items Excluding Goodwill
-3,933.0000
-1,582.0000
-2,952.0000
-9,783.1130
-10.2330
Total Unusual Items
-3,933.0000
-1,582.0000
-2,952.0000
-9,783.1130
-10.2330
Normalized EBITDA
-24,585.0000
-14,123.0000
-8,028.0000
-4,571.5220
-1,544.8260
Tax Rate for Calcs
--
--
0.0003
--
--
Tax Effect of Unusual Items
--
--
-773.7192
--
--
12/31/2020 - 8/20/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6628.HK Transcenta Holding Limited
0.610
0.00%
 
1228.HK CANBRIDGE-B
0.152
-1.94%
 
2105.HK Laekna, Inc.
10.840
-8.75%
 
2616.HK CStone Pharmaceuticals
2.710
+3.04%
 
PEPG PepGen Inc.
3.3800
-27.78%
 
TRDA Entrada Therapeutics, Inc.
17.84
+1.02%
 
ARGX.BR argenx SE
605.20
+4.20%
 
IMTX Immatics N.V.
7.14
-1.04%
 
ACOG Alpha Cognition Inc.
5.52
+1.85%
 
XLO Xilio Therapeutics, Inc.
0.9300
-4.00%